DBV Technologies S.A.

DBVTF ·Healthcare, Drug Manufacturers - General
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $700.0K $900.0K $562.0K $2.8M $1.5M $800.0K $511.0K $1.1M
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development $31.2M $33.4M $32.9M $28.6M $33.7M $21.5M $18.9M $23.7M
SG&A Expense $14.6M $10.5M $11.4M $7.3M $8.5M $5.6M $5.1M $7.2M
Operating Income $-50.6M $-47.9M $-45.1M $-34.3M $-41.1M $-26.6M $-23.9M $-30.3M
Operating Margin -7,228.6% -5,322.2% -8,021.2% -1,235.7% -2,740.0% -3,325.0% -4,669.5% -2,829.1%
Interest Expense — — — — — — — —
Pretax Income $-50.2M $-47.4M $-44.4M $-33.2M $-41.8M $-27.1M $-23.0M $-30.4M
Income Tax Expense $200.0K $200.0K $391.0K $0 $100.0K $0 $7.0K $0
Net Income $-50.4M $-47.6M $-44.8M $-33.2M $-41.9M $-27.1M $-23.0M $-30.4M
Net Margin -7,200.0% -5,288.9% -7,968.5% -1,195.5% -2,793.3% -3,387.5% -4,503.9% -2,839.7%
EPS (Basic) $-0.12 $-0.11 $-0.24 $-0.24 $-0.31 $-0.26 $-0.23 $-0.32
EPS (Diluted) $-0.12 $-0.11 $-0.24 $-0.24 $-0.31 $-0.26 $-0.23 $-0.32
Shares Outstanding (Basic) 433.5M 428.3M 139.6M 136.8M 134.5M 102.6M 97.0M 96.2M
Shares Outstanding (Diluted) 433.5M 428.3M 139.6M 136.8M 134.5M 102.6M 97.0M 96.2M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 4 Older →